Shaping the Future: India's Pathway to Pharmaceutical Quality Excellence

The Indian Pharmaceutical Alliance will host the 10th Global Pharmaceutical Quality Summit in Mumbai with the theme 'Navigating the Next Decade for Global Excellence'. It aims to gather industry leaders to discuss strategies for enhancing pharmaceutical quality and innovation, with key topics on AI, sustainability, and supply chain resilience.

The Indian Pharmaceutical Alliance is set to host the 10th Global Pharmaceutical Quality Summit in February 2025 at the J.W. Marriott Juhu in Mumbai. With a keen focus on 'Navigating the Next Decade for Global Excellence', the summit promises to gather industry titans, regulators, and experts to discuss the pressing issues and future directions in pharmaceutical quality and manufacturing.

During the inaugural session, Nilesh Gupta, Chair of IPA's Quality Forum and Managing Director of Lupin, will open proceedings. The keynote address will be delivered by Arvind Virmani, Hon'ble Member of NITI Aayog, Government of India, along with special remarks from Rajeev Raghuvanshi, Drug Controller General of India. A central feature of the summit will be a CEOs Panel Discussion involving leaders from Cipla, Lupin, Sun Pharma, and Zydus Lifesciences to explore strategic pathways for India to assume global leadership in quality excellence.

The summit will delve into critical topics such as AI-driven manufacturing, supply chain resilience, and sustainability in pharmaceuticals. Additionally, the event will mark the release of McKinsey's report 'Shaping the Future of India's Pharmaceutical Operations' along with IPA Best Practices Reports. This must-attend event is set to define Indian pharma's trajectory for the next decade, foregrounding quality as the cornerstone of growth and global dominance.

(With inputs from agencies.)